Neudexta (commonly referred to as the little red pill) has seen a meteoric rise in prescriptions in nursing homes in recent years. This, according to a recent report, has been the direct result of aggressive marketing that targets the frail and elderly residents of nursing homes. Humble beginnings of Neudexta Nuedexta was approved by the Food and Drug Administration (FDA) for the treatment of PsuedoBulbar Affect (PBA). This neurological … [Read more...]